The recently-released “Myanmar Opium Survey 2018” by the United Nations Office on Drugs and Crime (UNODC) entails specific accusations against several of the conflict actors. This commentary explains how this further distorts, rather than reflects, the complex realities in Myanmar.
An internal United Nations draft document leaked last weekend has offered outsiders a rare look at longstanding disagreements between member states over the course of U.N. drug policy. The document, first publicised by The Guardian and obtained by IPS, contains over 100 specific policy recommendations and proposals from member states, many at odds with the status quo on illicit drug eradication and prohibition.
This briefing paper looks at the issues raised by the publication in June of the latest World Drug Report by the United Nations Office on Drugs and Crime. The briefing paper analyses the developing data collection methodologies used by the UNODC and, while recognising their limitations, summarises the findings of the 2006 report on trends in the demand and supply of the main types of internationally prohibited drugs.
The "Beyond 2008" NGO Forum was held in Vienna, Austria from July 7-9, 2008. It was the final step in the global consultation of NGOs involved in responding to drug related problems and to provide civil society input for the 10-year UNGASS review.
Three draft resolutions and the draft declaration were subject to a line by line examination and intense debate. At the end of the Forum the Declaration and three Resolutions were adopted by consensus by all those participating in the Forum. This was an historic achievement and reflected the maturity and commitment of the global NGO community.
Since 1909 the international community has worked to eradicate the abuse of narcotics. A century on, the efforts are widely acknowledged to have failed, and worse, have spurred black market violence and human rights abuses. How did this drug control system arise, why has it proven so durable in the face of failure, and is there hope for reform?
A clear divide in drug control approaches became apparent at the end of the High Level Segment of the Commission on Narcotic Drugs (CND) on March 11-12 in Vienna, where countries gathered to review to progress since the 1998 UN General Assembly Special Session (UNGASS) and set a framework for the next 10 years through a Political Declaration and Plan of Action.
At one side of the divide a growing number of countries opt for pragmatic evidence-based harm reduction policies, while at the other side countries desperately cling to a zero tolerance approach that has failed to produce any significant result the past decade. Despite the diplomatic façade, the conclusion cannot be otherwise that the Vienna consensus on drug control that has paralysed progress in international drug control for decades, has fallen apart.
An extraordinary documentary marking a new level in broadcast journalism critiquing the international war on drugs was shown on Irish TV last on 3 June 2008. The report is a comprehensive indictment of the global drug war and asks if there is an alternative to this war without end.
The international drug control regime is facing the most profound challenge of its existence. Member states have for some time been experimenting with new responses to the ‘world drug problem’; however, the advent of legally regulated cannabis markets has resulted in a ratcheting up of these challenges to expose the system to new levels of strain. With the 2016 UN General Assembly Special Session (UNGASS) on the world drug problem fast approaching, how will the international community make use of the opportunity it provides for a free and open debate?
As the United Nations launches the 2009 World Drug Report this week, more than 40 international groups and experts worldwide today issued a call to action that presses governments to adopt a humane approach to drug policy.
The call to action, signed by the Transnational Institute (TNI), the Global Fund to Fight AIDS, Tuberculosis and Malaria, former president of Brazil Fernando Cardoso, and others, urges governments to enact policies that are based on scientific and medical research rather than politics.
In March 2014, country delegations will gather at the United Nations Commission on Narcotic Drugs (CND) to review progress and challenges in international drug control since the agreement of a Political Declaration on drugs in 2009. Given that the Political Declaration aims to “eliminate or reduce significantly” the use, supply and demand of controlled drugs by 2019, this meeting represents an important opportunity for honest evaluation and an acknowledgement that these targets are not being achieved. With a United Nations General Assembly Special Session (UNGASS) on drugs just two years away, this is an important time for international drug control policy.
Political representatives from over 130 countries gathered at a United Nations high level meeting in Vienna on March 11-12, 2009, to conclude a 2-year long review of progress achieved within the global drug control system. Despite calls from other UN agencies and international civil society urging the CND to affirm its support for harm reduction measures, and to rebalance the drug control system towards a public health and human rights approach, the new Political Declaration simply reaffirms the commitments of the 1998 UNGASS - repeating illusionary pledges for a society 'free of drug abuse' and setting another 10-year target date to eliminate or reduce significantly the illicit cultivation of opium poppy, coca bush and cannabis plant. This briefing paper examines the procedural and institutional factors that we believe have contributed to such a weak and incoherent outcome.
Meetings of the Commission on Narcotic Drugs (CND) are no forum for debate and change. The author, a former senior officer of the United Nations International Drug Control Programme (UNDCP), shows how CND meetings are manipulated in the interests of 17 developed countries that largely fund UNDCP – the CND’s ‘civil service’. However, these major donors are not united on policy or on how to apply the UN drug Conventions, so CND decisions reflect the lowest level of disagreement, with major splits on policy ignored.
As is now to be expected, the World Drug Report 2013 represents an impressive and wide-ranging set of data, analysis and policy prescription, and provides an overview of recent trends and the current situation in terms of production, trafficking, and consumption, including the consequences of illicit drug use on health. This year it also devotes considerable space to the phenomenon of New Psychoactive Substances (NPS).
In November 2011 I was invited by the Thai government to take part in an international delegation to develop a set of UN International Guiding Principles on Alternative Development. Our work began with a five-day journey along the Thai-Burma border to see first-hand the development programs that have been successful in virtually eliminating poppy production in that country. Over 100 government officials and experts from 28 countries visited the Thai “Royal Project,” which has research stations and development projects in five Northern provinces of the country.
In this response to the UNODC's World Drug Report 2008, the IDPC continues to support the concept of the Office acting in a capacity as a 'centre of expertise' that collates data, analysis and information on best practices, objectively facilitates policy debates between member states and civil society, and implements multilateral programmes. Nonetheless, it argues that there are still too many examples in the Report where the objectivity and expertise of the Office can be questioned.
This IDPC Briefing reviews the data in the latest report from the UN Office on Drugs and Crime on the state of the global market, criticises the claims made in the report that international action is successfully controlling the market, and questions the political objectivity of the UNODC as we approach the review of the global objectives set in 1998.
Ahead of the High-Level Segment on the world drug problem to take place on 13th and 14th January 2014, the UNODC Executive Director, Yuri Fedotov, has released his "contributions" to the debate. This 19-page document is, in parts, refreshingly honest about the “unequal” progress that has been made since 2009 (with reductions in supply or demand for some drugs in some places being offset by increases elsewhere), the setbacks and new challenges, and the fact that “the overall magnitude of drug demand has not substantially changed at the global level”.
Conflicting views and policies within the UN system on harm reduction have become a major concern. Consistency in messages is crucial especially where it concerns joint global programmes such as the efforts to slow down the HIV/AIDS epidemic; efforts in which harm reduction practices like needle exchange and substitution treatment play a pivotal role.